Cresco Labs Inc.

C$0.79As of Sun 8 Nov 2026, 12:00 UTC
CSE:CLHealthcare
Country Canada
PE (Fwd) •••
TSR 8Y CAGR (26.89%)
Div yield —
ROE (36.06%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.99
PE TTM —
TSR TTM (53.53%)
Mkt cap C$293.1M
ROIC 7.73%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.82
3.86%
2.53%
Hold 5|3|3|9|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
7.00%
7.07%
8.21%
23.11%
Revenue$M
25.61
25.12
25.10
25.38
4.75%
(1.83%)
(3.46%)
(3.70%)
Peers (US$207.4M)
Cap (US$)
PE
206.5M
15.78x
Capital
TTM
5Y
10Y
Leveragex
0.476
0.084
0.071
EBIT/Intx
0.960
0.092
0.094
Own earn%
60.97
222.57
204.26
Sh yield%
18.78
53.70
50.81
Owners
Insiders/Inst%
2.83
63.49
Short interest%
4.16
SBC / revenue%
4.80
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
29–34
$1 testx
−0.3
Incr. ROIC%
8